Clinical Implications of Head and Neck Cancer
The survival of tobacco-associated Head and Neck Squamous Cell Carcinoma (HNSCC) has not substantially changed over the past 30 years. Novel agents and strategies are being tested in several clinical trials. Quantitative imaging using computed tomography, magnetic resonance imaging, and positron emission tomography modalities plays a pivotal role in the design of clinical trials addressing molecularly targeted therapies.
- 4.2010 ACSCFaFACSGoogle Scholar